[DPHARMA] QoQ Quarter Result on 31-Mar-2022 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Mar-2022 [#1]
Profit Trend
QoQ- 29.11%
YoY- 15.2%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 151,960 177,074 181,742 185,941 145,444 171,838 155,439 -1.49%
PBT 15,347 21,385 21,473 26,646 17,128 22,483 20,197 -16.68%
Tax 1,814 -5,036 -5,162 -6,355 -1,412 -5,520 -4,807 -
NP 17,161 16,349 16,311 20,291 15,716 16,963 15,390 7.51%
-
NP to SH 17,161 16,349 16,311 20,291 15,716 16,963 15,390 7.51%
-
Tax Rate -11.82% 23.55% 24.04% 23.85% 8.24% 24.55% 23.80% -
Total Cost 134,799 160,725 165,431 165,650 129,728 154,875 140,049 -2.50%
-
Net Worth 657,045 647,522 634,375 621,987 621,564 612,147 614,350 4.56%
Dividend
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Div 17,140 - 4,734 - 16,951 - 3,530 185.91%
Div Payout % 99.88% - 29.02% - 107.86% - 22.94% -
Equity
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Net Worth 657,045 647,522 634,375 621,987 621,564 612,147 614,350 4.56%
NOSH 952,239 952,239 952,239 941,765 941,765 941,765 706,330 21.97%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 11.29% 9.23% 8.97% 10.91% 10.81% 9.87% 9.90% -
ROE 2.61% 2.52% 2.57% 3.26% 2.53% 2.77% 2.51% -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 15.96 18.60 19.19 20.03 15.44 18.25 22.01 -19.24%
EPS 1.80 1.72 1.72 2.19 1.67 1.80 2.18 -11.95%
DPS 1.80 0.00 0.50 0.00 1.80 0.00 0.50 134.34%
NAPS 0.69 0.68 0.67 0.67 0.66 0.65 0.87 -14.28%
Adjusted Per Share Value based on latest NOSH - 941,765
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 15.79 18.39 18.88 19.32 15.11 17.85 16.15 -1.48%
EPS 1.78 1.70 1.69 2.11 1.63 1.76 1.60 7.34%
DPS 1.78 0.00 0.49 0.00 1.76 0.00 0.37 184.16%
NAPS 0.6825 0.6726 0.659 0.6461 0.6457 0.6359 0.6382 4.56%
Price Multiplier on Financial Quarter End Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 -
Price 1.61 1.30 1.20 1.49 1.68 1.81 3.03 -
P/RPS 10.09 6.99 6.25 7.44 10.88 9.92 13.77 -18.67%
P/EPS 89.34 75.72 69.66 68.17 100.67 100.49 139.03 -25.47%
EY 1.12 1.32 1.44 1.47 0.99 1.00 0.72 34.14%
DY 1.12 0.00 0.42 0.00 1.07 0.00 0.17 250.23%
P/NAPS 2.33 1.91 1.79 2.22 2.55 2.78 3.48 -23.41%
Price Multiplier on Announcement Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 23/02/23 09/11/22 16/08/22 17/05/22 15/02/22 18/11/21 17/08/21 -
Price 1.65 1.39 1.34 1.51 1.60 1.62 2.49 -
P/RPS 10.34 7.47 6.98 7.54 10.36 8.88 11.31 -5.78%
P/EPS 91.56 80.96 77.78 69.08 95.88 89.94 114.25 -13.68%
EY 1.09 1.24 1.29 1.45 1.04 1.11 0.88 15.29%
DY 1.09 0.00 0.37 0.00 1.13 0.00 0.20 208.73%
P/NAPS 2.39 2.04 2.00 2.25 2.42 2.49 2.86 -11.25%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment